Glycopyrronium 25mcg Respule in PCD pharma franchise in Hyderabad

Glycopyrronium 25mcg Respule in pharmaceutical manufacturing company in Mumbai

Glycopyrronium 25mcg Respule in respiratory care pharma franchise in Pune

Glycopyrronium 25mcg Respule in pharma suppliers in Delhi

Glycopyrronium 25mcg Respule in pharma export companies in Kolkata
Glycopyrronium 25mcg Respule in pharma franchise opportunities in Bengaluru

Home/Products /glycopyrronium-ip-25-mcg-respule

Glycopryl 25 Respule

Composition : Glycopyrronium (25mcg) Respule

Dosage Form : Respule

Packaging Type : Pack

Packaging : 4x5x2ml

Price : ₹350/-

Glycopyrronium IP 25 mcg Respule is a long-acting muscarinic antagonist (LAMA) bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). It works by blocking the M3 receptors in airway smooth muscles, leading to sustained bronchodilation and improved airflow. The formulation offers effective once-daily maintenance treatment, helping reduce symptoms like breathlessness, wheezing, and chronic cough.

Read More

About the Product

Glycopyrronium IP 25 mcg Respule is a long-acting muscarinic antagonist (LAMA) bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). It works by blocking the M3 receptors in airway smooth muscles, leading to sustained bronchodilation and improved airflow. The formulation offers effective once-daily maintenance treatment, helping reduce symptoms like breathlessness, wheezing, and chronic cough.

Glycopyrronium is usually well tolerated. Some patients may experience dry mouth, constipation, sore throat, or urinary tract infection. Less commonly, dizziness, palpitations, or hypersensitivity reactions may occur. If severe side effects develop, consult a physician immediately.

This respule is indicated for long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is not intended for the relief of acute bronchospasm or as a rescue therapy during sudden breathing difficulty.

Use only as prescribed by a registered medical practitioner. Not to be used for acute episodes of bronchospasm. Do not exceed the recommended dose. Always use with a nebulizer device as directed. Avoid contact with eyes.

Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation